DEF 14A: Pro-Dex, Inc. Reports Record Sales and Announces Annual Shareholder Meeting

Pro-Dex, Inc. announces its annual shareholder meeting and highlights a record year with $53 million in sales and expansion plans.

Summary

• Pro-Dex, Inc. had a record year in fiscal 2024, achieving $53 million in annual sales and a $15 million sales quarter.
• The company has experienced sales growth for nine consecutive years.
• Pro-Dex has doubled its capacity with a second operational building and is investing in business development and its website.
• The annual shareholder meeting will be held on November 21, 2024, to elect seven directors, ratify the appointment of Moss Adams, LLP as the independent accounting firm, and hold an advisory vote on executive compensation.
• Shareholders of record as of September 24, 2024, are entitled to vote at the meeting.
• The Board of Directors recommends voting for the election of the director nominees and for Proposals 2 and 3.
• The company's common stock outstanding as of September 24, 2024, was 3,322,854 shares.

Sentiment

Score: 8

Explanation: The document expresses a positive outlook with record sales and expansion plans, indicating strong confidence in the company's future.

Positives

• Pro-Dex achieved record annual sales and a record sales quarter.
• The company has a history of consistent sales growth.
• Capacity has been doubled with a new building, supporting future growth.
• The company is investing in business development and its online presence.
• The Board is actively engaged in risk oversight and corporate governance.
• The company has a comprehensive and balanced compensation plan that includes a base salary; discretionary bonuses upon evaluation of Company and personal performance; performance awards generally payable in shares of Common Stock upon the satisfaction of various service periods and the market price of our Common Stock achieving certain pre-determined prices; stock options; and, a package of benefits similar in scope and nature to those offered to all our other employees.

Risks

• The document does not explicitly mention any specific risks, but general business risks associated with growth and market conditions are implied.
• The company's stock price is subject to market fluctuations, which could impact the value of equity-based compensation.

Future Outlook

Pro-Dex has aggressive growth plans and is focused on improving the patient and doctor experience.

Management Comments

• Rick Van Kirk, President and CEO: 'Fiscal 2024 was an outstanding year with another record for annual sales of $53M and our first $15M sales quarter.'
• Rick Van Kirk, President and CEO: 'We are proud of the fact that the team has achieved sales growth for nine consecutive years.'
• Rick Van Kirk, President and CEO: 'We are excited about the future.'

Industry Context

The document does not provide specific industry context beyond Pro-Dex's focus on medical devices and improving patient/doctor experiences.

Related Party Transactions

• Pro-Dex has invested in Air T, Inc., where two of Pro-Dex's board members also serve as board members or executives.
• Rick, Pro-Dex's CEO, is a board member of Monogram Technologies Inc., in which Pro-Dex owns shares.

Stakeholder Impact

• Shareholders will vote on key proposals affecting the company's direction and governance.
• Employees may benefit from the company's growth and investments in business development.
• Customers and patients may experience improved products and services as a result of the company's focus on their needs.

Next Steps

• Shareholders are urged to vote on the proposals outlined in the proxy statement.
• The company will hold its annual meeting on November 21, 2024.
• The company will continue to execute its growth plans and invest in business development.

Key Dates

Keywords

shareholder meeting, proxy statement, directors, executive compensation, Moss Adams, annual sales, Pro-Dex, governance, investment